Literature DB >> 23816567

Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation.

Jin Zhang1, Zhanguo Gao, Jianping Ye.   

Abstract

S6K (ribosomal S6 kinase p70, p70S6K) activation requires phosphorylation at two stages. The first phosphorylation is independent of insulin stimulation and mediated by an unknown kinase. The second phosphorylation is mediated by mTOR in insulin dependent manner. In this study, we identified JNK1 (c-Jun N-terminal kinase 1) as a kinase in the first phosphorylation. S6K protein was phosphorylated by JNK1 at S411 and S424 in the carboxyl terminal autoinhibitory domain. The phosphorylation was observed in kinase assay with purified S6K as a substrate, and in cells after JNK1 activation by TNF-α or MEKK1 expression. The phosphorylation was detected in JNK2 null cells, but not in JNK1 null cells after TNF-α treatment. When JNK1 activation was inhibited by MKK7 knockdown, the phosphorylation was blocked in cells. The phosphorylation led to S6K protein degradation in NF-κB deficient cells. The degradation was blocked by inhibition of proteasome activity with MG132. In wide type cells, the phosphorylation did not promote S6K degradation when IKK2 (IKKβ, IκB kinase beta) was activated. Instead, the phosphorylation allowed S6K activation by mTOR, which stabilizes S6K protein. In IKK2 null cells or cells treated by IKK2 inhibitor, the phosphorylation led to S6K degradation. These data suggest that S6K is phosphorylated by JNK1 and the phosphorylation makes S6K protein unstable in the absence of IKK2 activation. This study provides a mechanism for regulation of S6K protein stability.
© 2013.

Entities:  

Keywords:  Inflammation; Insulin resistance; Liver; Obesity; TNF-α

Mesh:

Substances:

Year:  2013        PMID: 23816567      PMCID: PMC3825840          DOI: 10.1016/j.bbadis.2013.06.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

Review 1.  Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.

Authors:  Brian Magnuson; Bilgen Ekim; Diane C Fingar
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Regulation of ribosomal protein S6 kinases by ubiquitination.

Authors:  Mong-Lien Wang; Ganna Panasyuk; Jodie Gwalter; Ivan Nemazanyy; Tim Fenton; Valeriy Filonenko; Ivan Gout
Journal:  Biochem Biophys Res Commun       Date:  2008-02-15       Impact factor: 3.575

3.  The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase.

Authors:  J Gwalter; M-L Wang; I Gout
Journal:  Int J Biochem Cell Biol       Date:  2008-08-22       Impact factor: 5.085

4.  Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro.

Authors:  S Isotani; K Hara; C Tokunaga; H Inoue; J Avruch; K Yonezawa
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

5.  Identification of a conserved motif required for mTOR signaling.

Authors:  Stefanie S Schalm; John Blenis
Journal:  Curr Biol       Date:  2002-04-16       Impact factor: 10.834

6.  A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.

Authors:  O N Ozes; H Akca; L D Mayo; J A Gustin; T Maehama; J E Dixon; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

7.  Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase.

Authors:  Jason A Lehman; Victor Calvo; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2003-05-11       Impact factor: 5.157

8.  Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

Authors:  Zhanguo Gao; Daniel Hwang; Fredly Bataille; Michael Lefevre; David York; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

9.  Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.

Authors:  Frédéric Tremblay; Sophie Brûlé; Sung Hee Um; Yu Li; Kohei Masuda; Michael Roden; Xiao Jian Sun; Michael Krebs; Roberto D Polakiewicz; George Thomas; André Marette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

10.  Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K.

Authors:  Zhanguo Gao; Jun Yin; Jin Zhang; Qing He; Owen P McGuinness; Jianping Ye
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

View more
  16 in total

1.  Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo.

Authors:  Jonas Elias Schweig; Hailan Yao; Kyle Coppola; Chao Jin; Fiona Crawford; Michael Mullan; Daniel Paris
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

2.  TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.

Authors:  Jonathan M Cooper; Yi-Hung Ou; Elizabeth A McMillan; Rachel M Vaden; Aubhishek Zaman; Brian O Bodemann; Gurbani Makkar; Bruce A Posner; Michael A White
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

Review 3.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

4.  Maternal Diet Quality Is Associated with Placental Proteins in the Placental Insulin/Growth Factor, Environmental Stress, Inflammation, and mTOR Signaling Pathways: The Healthy Start ECHO Cohort.

Authors:  Ellen C Francis; Dana Dabelea; Kristen E Boyle; Thomas Jansson; Wei Perng
Journal:  J Nutr       Date:  2022-03-03       Impact factor: 4.798

5.  mTORC1 and JNK coordinate phosphorylation of the p70S6K1 autoinhibitory domain in skeletal muscle following functional overloading.

Authors:  Tony D Martin; Michael D Dennis; Bradley S Gordon; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-06       Impact factor: 4.310

6.  Activation of the Stress Response Kinase JNK (c-Jun N-terminal Kinase) Attenuates Insulin Action in Retina through a p70S6K1-dependent Mechanism.

Authors:  William P Miller; Suhana Ravi; Tony D Martin; Scot R Kimball; Michael D Dennis
Journal:  J Biol Chem       Date:  2016-12-13       Impact factor: 5.157

7.  The Dephosphorylation of p70S6 (Thr389) Kinase as a Marker of L-Glutamate-Induced Excitotoxicity Related to Diabetes Disturbances-an Unconventional In Vitro Model.

Authors:  Anna Rorbach-Dolata; Anna Kicinska; Agnieszka Piwowar
Journal:  Neurotox Res       Date:  2020-01-04       Impact factor: 3.911

8.  ROS Inhibits Cell Growth by Regulating 4EBP and S6K, Independent of TOR, during Development.

Authors:  Ashish G Toshniwal; Sakshi Gupta; Lolitika Mandal; Sudip Mandal
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 13.417

9.  Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism.

Authors:  Thomas W Frazier; Ritika Jaini; Robyn M Busch; Matthew Wolf; Tammy Sadler; Patricia Klaas; Antonio Y Hardan; Julian A Martinez-Agosto; Mustafa Sahin; Charis Eng
Journal:  Mol Autism       Date:  2021-01-28       Impact factor: 7.509

10.  CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.

Authors:  Hiroyuki Matsui; Kotaro Shirakawa; Yoshinobu Konishi; Shigeki Hirabayashi; Anamaria Daniela Sarca; Hirofumi Fukuda; Ryosuke Nomura; Emani Stanford; Yoshihito Horisawa; Yasuhiro Kazuma; Tadahiko Matsumoto; Hiroyuki Yamazaki; Yasuhiro Murakawa; Emilie Battivelli; Eric Verdin; Yoshio Koyanagi; Akifumi Takaori-Kondo
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.